Table 2. Toxin profile of ETEC isolates from cases and from controls by continent and across all seven GEMS sites combined.
| Africa | Asia | Asia & Africa | ||||
|---|---|---|---|---|---|---|
| Toxin Profile | Cases (N = 510) |
Controls (N = 480) |
Cases (N = 296) |
Controls (N = 231) |
Cases (N = 806) |
Controls (N = 711) |
| LT-only | 171 (33.5%)* | 249 (51.9%)+ | 85 (28.7%)# | 84 (36.4%)$ | 256 (31.8%) | 333 (46.8%) |
| Any ST-only | 182 (35.7%)* | 98 (20.4%)+ | 109 (36.8%)# | 48 (20.8%)$ | 291 (36.1%) | 146 (20.5%) |
| STh-only | 177 (34.7%)* | 94 (19.6%)+ | 107 (36.1%)# | 40 (17.3)$ | 284 (35.2%) | 134 (18.8%) |
| STp-only | 5 (1.0%)* | 4 (0.8%)+ | 2 (0.7%)# | 7 (3.0%)$ | 7 (0.9%) | 11 (1.5%) |
| STh/STp | 0 (0%)* | 0 (0%)+ | 0 (0%)# | 1 (0.4%)$ | 0 (0%) | 1 (0.1%) |
| All LT/ST | 157 (30.8%)* | 133 (27.7%)+ | 102 (34.5%)# | 99 (42.9%)$ | 259 (32.1%) | 232 (32.6%) |
| LT/STh | 104 (20.4%)* | 65 (13.5%)+ | 74 (25.0%)# | 30 (13.0%)$ | 178 (22.1%) | 95 (13.4%) |
| LT/STp | 53 (10.4%)* | 67 (14.0%)+ | 27 (9.1%)# | 69 (29.9%)$ | 80 (9.9%) | 136 (19.1%) |
| LT/STh/STp | 0 (0%)* | 1 (0.2%)+ | 1 (0.3%)# | 0 (0%)$ | 1 (0.1%) | 1 (0.1%) |
| All ST-only + all LT/ST | 339 (66.5%)* | 231 (48.1%)+ | 211 (71.3%)# | 147 (63.6%)$ | 550 (68.2%) | 378 (53.2%) |
Data presented are the number of ETEC strains (and percentages) with the indicated toxin profile
* Percent of 510
+ Percent of 480
# percent of 296
$ Percent of 231